Dr. Gainor is a graduate of Johns Hopkins University in Baltimore, MD and Harvard Medical School in Boston, MA. He completed his Internal Medicine residency at the Massachusetts General Hospital in Boston, MA and his Medical Oncology fellowship in the Dana-Farber Cancer Institute/Partners Cancer Care program. He is currently an Attending Physician in the Center for Thoracic Cancers at the Massachusetts General Hospital Cancer Center and an Instructor in Medicine at Harvard Medical School.
Dr. Gainor has an active clinical and translational research career. His research focuses on the development of novel targeted therapies in genetically-defined subsets of non-small cell lung cancer, with a focus on chromosomal rearrangements (ALK, ROS1, and RET). As part of this work, he is active in studying molecular mechanisms of resistance to targeted therapies, as well as the intersection of targeted therapies and immunotherapies, on both a clinical and translational level.
- Instructor in Medicine
Harvard Medical School